Tehran University of Medical Sciences

Science Communicator Platform

Stay connected! Follow us on X network (Twitter):
Share this content! On (X network) By
Vaccines for Preventing Cutaneous Leishmaniasis Publisher



Khanjani N1 ; Gonzalez U2 ; Leonardibee J3 ; Mohebali M4 ; Saffari M5 ; Khamesipour A6
Authors
Show Affiliations
Authors Affiliations
  1. 1. Kerman Medical University (KMU), Department of Epidemiology and Biostatistics, Faculty of Public Health, Haft Bagh Alavi Blvd, Kerman, 76169-11317, Iran
  2. 2. CLlNICA GO and FER, Unit of Dermatology, Riera Blanca 6-8, LHospitalet, Barcelona, 08903, Spain
  3. 3. The University of Nottingham, Division of Epidemiology and Public Health, Clinical Sciences Build, Hospital NHS Campus, Hucknall Rd, Nottingham, NG5 1PB, United Kingdom
  4. 4. Tehran University of Medical Sciences, School of Public Health, P.O. Box: 14155-6446, Tehran, Iran
  5. 5. Shahid Bahonar University of Kerman, College of Agriculture, P.O. Box 76135-666, Kerman, Iran
  6. 6. Tehran University of Medical Sciences (TUMS), Center for Research and Training in Skin Diseases and Leprosy, No. 79 Taleghani Avenue, P.O. Box 14155-6383, Tehran, 14166, Iran

Source: Cochrane Database of Systematic Reviews Published:2018


Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To evaluate if vaccination with each of the different available vaccines reduces the occurrence of cutaneous leishmaniasis (CL) in endemic regions © 2018 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Related Docs
View other Related Docs
1. An Overview of Leishmanization Experience: A Successful Control Measure and a Tool to Evaluate Candidate Vaccines, Acta Tropica (2019)
2. Immunization Against Cutaneous Leishmaniasis by Alginate Microspheres Loaded With Autoclaved Leishmania Major (Alm) and Quillaja Saponins, Iranian Journal of Pharmaceutical Research (2016)
3. Immunization Against Leishmania Major Infection in Balb/C Mice Using a Subunit-Based Dna Vaccine Derived From Tsa, Lmsti1, Kmp11, and Lack Predominant Antigens, Iranian Journal of Basic Medical Sciences (2019)
4. Double-Blind Randomized Efficacy Field Trial of Alum Precipitated Autoclaved Leishmania Major (Alum-Alm) Vaccine Mixed With Bcg Plus Imiquimod Vs. Placebo Control Group, Iranian Journal of Parasitology (2015)
5. Evaluation of Immune Response Against Leishmaniasis in Balb/C Mice Immunized With Cationic Dotap/Dope/Chol Liposomes Containing Soluble Leishmania Major Antigens, Iranian Journal of Parasitology (2019)
6. Pegylation of Cationic Liposomes Encapsulating Soluble Leishmania Antigens Reduces the Adjuvant Efficacy of Liposomes in Murine Model, Parasite Immunology (2017)
7. Development of Nano-Carriers for Leishmania Vaccine Delivery, Expert Opinion on Drug Delivery (2020)
8. Cationic Liposomes Formulated With a Novel Whole Leishmania Lysate (Wll) As a Vaccine for Leishmaniasis in Murine Model, Immunobiology (2018)
Experts (# of related papers)
View all Related Experts
Mahdi Mohebali (6)
Alireza Firooz (2)
Other Related Docs
9. Potential Biomarkers of Immune Protection in Human Leishmaniasis, Medical Microbiology and Immunology (2021)
10. Determination of the Effective Dose of Curcumin Alone and in Combination With Antimicrobial Peptide Cm11 on Promastigote Forms of Iranian Strain of L. Major (Mrho / Ir / 75 / Er); [Determination De La Dose Efficace De Curcumine Seule Et En Association Avec Le Peptide Antimicrobien Cm11 Sur La Forme Promastigote De La Souche Iranienne Leishmania Major (Mrho/Ir/75/Er)], Archives of Razi Institute (2019)
11. Engineering and Design of Promising T-Cell-Based Multi-Epitope Vaccine Candidates Against Leishmaniasis, Scientific Reports (2023)
12. An Alphavirus-Derived Self-Amplifying Mrna Encoding Ppsp15-Lmsti1 Fusion Protein for the Design of a Vaccine Against Leishmaniasis, Parasitology International (2022)
13. Sphingomyelin Liposome Bearing Whole Leishmania Lysate Antigens Induce Strong Th2 Immune Response in Balb/C Mice, Iranian Journal of Basic Medical Sciences (2021)
14. Geographic Distribution and Spatial Analysis of Leishmania Infantum Infection in Domestic and Wild Animal Reservoir Hosts of Zoonotic Visceral Leishmaniasis in Iran: A Systematic Review, Journal of Vector Borne Diseases (2018)
15. Comparison of Cytokine Profile of Ifn-Γ, Il-5 and Il-10 in Cutaneous Leishmaniasis Using Pbmc Vs. Whole Blood, Iranian Journal of Microbiology (2019)
16. Coadminstration of L. Major Amastigote Class I Nuclease (Rlmacin) With Lpd Nanoparticles Delays the Progression of Skin Lesion and the L. Major Dissemination to the Spleen in Balb/C Mice-Based Experimental Setting, Acta Tropica (2016)
17. Cationic Immune Stimulating Complexes Containing Soluble Leishmania Antigens: Preparation, Characterization and in Vivo Immune Response Evaluation, Iranian Journal of Immunology (2015)
18. Study on Knowledge, Attitude and Practice of Health Workers of East Azerbaijan, Ilam and Khorasan Razavi Provinces About Leishmaniasis During 2015-2016: A Comparative Study Before and After Intervention, Archives of Clinical Infectious Diseases (2019)
19. The Role of Lpd-Nanoparticles Containing Recombinant Major Surface Glycoprotein of Leishmania (Rgp63) in Protection Against Leishmaniasis in Murine Model, Immunopharmacology and Immunotoxicology (2018)
20. The Role of Iscomatrix Bilayer Composition to Induce a Cell Mediated Immunity and Protection Against Leishmaniasis in Balb/C Mice, Iranian Journal of Basic Medical Sciences (2016)
21. Comparative Analysis of Microscopy, Leishmanin Skin Test (Lst), and Direct Agglutination Test (Dat) for the Diagnosis of Human Cutaneous Leishmaniasis, Iranian Journal of Parasitology (2025)
22. Lived Experiences of Patients Suffering From Acute Old World Cutaneous Leishmaniasis: A Qualitative Content Analysis Study From Iran, Journal of Arthropod-Borne Diseases (2018)